AXIM Biotechnologies Announces Clinical Trial Launch of MedChew RX for Treatment of Pain and Spasticity in Multiple Sclerosis and Development of Pharmaceutical Cannabis Chewing Gum

AXIM Biotechnologies Announces Clinical Trial Launch of MedChew RX for Treatment of Pain and Spasticity in Multiple Sclerosis and Development of Pharmaceutical Cannabis Chewing Gum

Clinical Trials Conducted on the World’s First Patented Cannabinoid Release Chewing Gum Medical Marijuana, Inc. (OTC Pink:MJNA) is an agricultural hemp industry innovator that sources, evaluates, invests in and acquires value-adding companies with a focus on...

Medical Marijuana Inc. Portfolio Company CanChew BioTechnologies Inc. Announces Final Day for Market Survey and Free Product Trial Registration

SAN DIEGO, Nov. 15, 2012 /PRNewswire/ — CanChew BioTechnologies Inc, a portfolio company of Medical Marijuana Inc. (OTC: MJNA), announces that this is the final day to register for the market trial of CanChew gum.  Qualifying participants will receive a minimum...